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ABSTRACT
obacco is an important cash crop in American 
farming, native to North and South American 
1Tcontinent . The use of tobacco leaf to create and 
satisfy nicotine addiction was introduced to Columbus 
thby Native Americans in 14  century and spread rapidly 
1to Europe.
The use of tobacco as cigarette, however, is 
thpredominantly a 20  century phenomenon just as the 
1epidemic of disease caused by this form of tobacco use . 
Nicotine is the principal constituent of tobacco 
responsible for its additive characteristics. Addictive 
smokers regulate their nicotine intake and blood levels 
by adjusting the frequency and intensity of their 
tobacco use to obtain the desired psychoactive effect 
1and avoid withdrawal . Tobacco use is a powerful, 
independent predictor of deaths related to 
cardiovascular disease and is an important contributor 
to deaths from major chronic diseases. Unfortunately, 
increasing rates of tobacco use throughout the world is 
contributing significantly to the burden of death and 
disability from these diseases, especially in developing 
countries. If current trends continue, the annual 
numbers of people killed by tobacco use will more than 
2triple, to 10 million by 2030.
REASONS FOR TOBACCO ABUSE 
Approximately 90% of individuals who will become 
3smokers initiate the behavior during adolescence.  
Factors that promote adolescent initiation are parental 
or older generation cigarette smoking, tobacco 
advertisement and promotional activities, the 
availability of cigarette, culture, and the social 
acceptability of smoking. Others include the need for 
an enhanced self image and to initiate adult behavior. It 
is greater among those adolescents who have the least 
external validation of their self worth. This may explain 
in part the enormous difference in adolescent smoking 
prevalence by socioeconomic and school performance 
3strata .
Genetic considerations:
Several genes have been associated with nicotine 
4 addiction. Some reduce the clearance of nicotine and 
others have been associated with increased likelihood 
of becoming dependant on tobacco and other drugs as 
4well as a higher incidence of depression.  Genetic 
alteration that involves the neurotransmitter 
dopamine, serotogenic and cholinergic neuro-
regulatory pathways are being explored but their 
contribution to development and maintenance of 
nicotine addiction remains to be determined. It is 
unlikely that genetic factors are the principal 
5determinants of addiction.  The rate of smoking 
initiation among males and corresponding rates of 
nicotine addiction have dropped by almost 50% since 
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commonly and idiomatically as dip  and 
sometimes as rub, other terminology used to 
describe moist snuff include: chew, chaw, 
12 daps, bacca and  spit tobacco. The shredded 
tobacco is easily introduced into the oral 
cavity. It could also be deposited in the cheek 
and gum resulting in gum disease and oral 
13cancers.
3. Snuff: It is also a smokeless tobacco made from 
ground or pulverized tobacco leaves, it is 
insufflated or snuffed into the nasal cavity, into 
each nostril, delivering a swift hit of nicotine. 
Traditionally it is sniffed or inhaled lightly 
after a pinch of snuff is placed onto the back 
surface of the hand. This has the effect of 
causing inflammation of the nasal mucosa, loss 
of intra nasal hair and loss of secretion of 
sebum which lubricates the skin layer within 
the upper airway. All this culminate in the loss 
of external defense mechanism of the upper 
airway thereby rendering it more susceptible 
to upper respiratory tract infections, intense 
inflammation and mutation of the cellular 
14lining.
4. Beedi: This form of tobacco is a thin cigarette 
filled with tobacco flakes wrapped in a paper 
or “temburni” leaf, it is a traditional method of 
tobacco use throughout south Asia and part of 
15the middle east.  Today beedies are popular 
and inexpensive and its use tend to be 
16associated with lower social standing.  Its use 
is associated with high nicotine, carbon 
monoxide and tar content and carry greater 
risk of  chronic gum disease and can result in 
17oral cancer.
5. Chatta: This is a coarsely prepared medium 
size particle which is wrapped in a dried 
tobacco or jack fruit leaves. It is smoked with 
the burning end inside the mouth. Its use is 
common in parts of India and Latin America 
3e.g. Peru.
6. Chillum and sulpha: Both are clay pipes in 
which dried tobacco leaves is pounded and is 
smoked. Chillum smoking is practiced in parts 
of India and Sulpha smoking in parts of rural 
Nepal. The culture of owning and smoking a 
chillium has spread from India to the rest of the 
3world.
7. S i s h a ,  H o o k a ,  G o z a  a n d  H u b b l e :
Tobacco mixed with molasses is burnt and the 
smoke is passed through water before 
inhalation. The hubble-bubble apparatus is 
usually passed round from person to person in 
a form of group smoking making transmission 
of respiratory tract infections a risk. Hookah 
smoking is prevalent in Bangladesh, India, 
Nepal and Pakistan; Goza smoking is 
 
the 1950s, suggesting that factors other than genetics 
5are the principal determinants of addiction.  It is more 
likely that genetic polymorphism represents a range of 
biologic susceptibility conditioning, the intensity of 
cigarette use and the probability that experimentation 
with tobacco as an adolescent leads to addiction as an 
3,4adult 
In Africans in addition to the abuse factors, smoking is 
more common in the low socioeconomic and less 
educated populace particularly in the field laborers 
who believe nicotine makes them alert and ease fatigue 
6in order to do more work to enhance more pay. Some 
indulge in smoking as a way of letting off mental stress, 
6due to poverty as a result of failure to achieve a goal.
Gender:
Recently in the west despite male dominance there has 
been an increase in smoking habit among female adults 
in high schools and college institutions which is 
basically due to pair smoking, exposure to western 
movies, role of parent smoking, self concept coupled 
with the freedom the female child gets when she is 
away from home where parental supervision is less 
attainable. Many have the mind of quitting after 
graduation, but become addicted eventually, however 
overall there is still male predominance in smoking in 
most societies with some up to 95% male dominance 
7, 8recorded.
Environmental exposure
The health hazard due to exposure to environmental 
tobacco smoke (ETS) are increasingly established, ETS 
contains thousands of chemicals including 43 known 
9carcinogens .
Other determinants are family problems, lack of 
7, 8knowledge, siblings and friend's use.
TYPES OF TOBACCO AND MODE OF ABUSE
1. Cigarette: This is the most widely used form of 
tobacco, partly due to its wide availability and 
affordability thereby making it more accessible 
to all socio-economic class. It is a fine cylinder 
of finely cut tobacco leaves rolled in thin paper 
for smoking. Most modern manufactured 
cigarette also called ready rolls, is filtered and 
includes reconstituted tobacco and other 
10additives.  Its absorption through the oral 
mucosa is almost impossible and so smokers 
have to inhale into the lungs in order to achieve 
the desired effect, where it causes more harm 
11to the airways .
2. Moist snuff: This is another form of tobacco 
which is widely use in sub-Saharan Africa. It is 
finely grounded or shredded, moistened 
smokeless tobacco leaf, it is also referred 
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cancer, when tobacco is burnt, the resultant smoke 
contains, in addition to nicotine, carbon monoxide and 
74,000 other compounds that result from volatization, 
1pyrolysis and pyrosynthesis of tobacco products.  The 
smoke is composed of a fine aerosol, with a particle size 
distribution predominantly in the airways and alveoli 
surfaces of the lungs, and a vapor phase. The bulk of the 
toxicity and carcinogenicity of the smoke resides in the 
aerosolized and particulate phase, which contains a 
large number of toxic constituents that has over 40 
1carcinogenic compounds.
The aggregate of particulate matter after subtracting 
nicotine and moisture, is referred to as tar. The vapor 
phase contains carbon monoxide, respiratory irritants, 
and ciliotoxins as well as many of the volatile 
compounds responsible for the distinctive smell of 
1cigarette smoke.  The alkaline Ph of smoke from blends 
of tobacco used for pipes and cigars tend to prevent the 
smoke inhalation into the lung, confining the toxic and 
carcinogenic exposure largely to the upper airways for 
1most users of these products.  The acidic Ph of smoke 
generated by the tobacco used in cigarettes 
dramatically reduces absorption of nicotine in the 
mouth necessitating inhalation of the smoke into the 
larger surface of the lungs, in order to absorb enough 
quantities of nicotine sufficient to satisfy the smoker's 
addiction. The shift to using tobacco as cigarette, with 
resultant increased deposition of smoke in the lung has 
increased the epidemics of heart disease, lung diseases 
and lung cancer that dominate the current disease 
1, 19manifestations of tobacco use.  
EFFECT OF TOBACCO ABUSE ON HEALTH
Over 400,000 individuals die prematurely each year in 
the United States from cigarette use. Approximately 
40% of cigarette smokers will die prematurely due to 
1, 24cigarette smoking unless they quit.  In Africa the 
effect of tobacco appears much earlier and its more 
devastating probably because of low socio-economic 
status, poor health facilities, lack of good health 
25insurance policies among others.  All of these leads to 
the adverse effect of tobacco in the developing 
25countries.  The incidence of smoking related disease is 
proportionately greater in younger than in older 
smokers, particularly for coronary artery disease and 
8, 26,  stroke. At older age the rate of disease in non 
smokers increase, diminishing the fractional 
contribution of smoking and the relative risk. 
However, absolute excess rates of disease compared to 
non smokers increase with increasing age. The organ 
damage caused by smoking and the number of 
smokers who die from smoking are both greater among 
elderly as one would expect from the process of 
1, 27cumulative injury.
CARDIOVASCULAR DISEASE: Cigarette smokers 




prevalent in Egypt and the countries of South-
3West Asia.
8. Smokeless Tobacco and e-cigarette:  These 
are new products and have become 
increasingly popular in the western world over 
the last few years; they produce vapour from 
nicotine dissolved in propylene glycol or 
glycerine. Low levels of contaminating 
chemicals have been found in them but e-
cigarettes are almost certainly far safer than 
smoking cigarettes. E-cigarettes may have the 
potential to help smokers escape their deadly 
addiction to tobacco, however more evidence 
is needed to prove this – there have only been a 
few small trials so far. And these new products 
are not regulated yet, so they can vary 
significantly in quality and any possible long-
term risks are not known. At the moment there 
is great debate about the wider impact of e-
cigarettes. They could potentially save 
millions of smokers by providing the option 
for them to swap to a less harmful product. Or 
they could be used along with cigarettes and 
sustain addiction or renormalize smoking.
All forms of burnt tobacco generate toxic and 
carcinogenic smoke similar to that of cigarette smoke. 
The difference in disease consequence on tobacco use 
18 relates to frequency of use and depth of inhalation.
The risk of upper airway cancer is similar among 
cigarette and cigar smokers while those who have 
smoked only once have a much lower risk of lung 
cancer, heart disease and chronic obstructive 
19pulmonary disease.  It suffices to know that cigarette 
smokers who switch to pipes or cigars tend to inhale the 
smoke thereby increasing their risk of exposure and it is 
likely that comparable inhalation and frequency of 
exposure to tobacco smoke from any of these forms of 
tobacco use is associated with a resurgence of cigar and 
bidi use among adolescents of both genders, raising 
concern that these older forms of tobacco are once again 
17causing a public health concern.
LOWER TAR AND NICOTINE CIGARETTE: The 
toxicity of cigarette smoke is contained in the tar while 
nicotine is the principal additive agent in cigarette, it 
has been suggested that cigarette that delivers low tar 
20, 21and nicotine to the smoker might not be safer.  There 
is 10-20% reduction in risk of developing lung cancer 
when tar yield is reduced by 75% and this holds if there 
is no compensatory increase in intensity of smoking 
and is not likely to reduce cancer risk for sites other 
22, 23than lungs, larynx, esophagus and mouth.
BIOCHEMICAL CONTENT OF TOBACCO: Un 
burnt tobacco contains nicotine, carcinogen and other 
toxins capable of causing gum disease, lungs and oral 
356
Nigerian Journal of Medicine, Vol. 24 No. 4, October - December, 2015, ISSN 1115-2613
expiratory airflow with reduction in FEV , FVC, AND 1
FEV /FVC sufficient to produce clinical symptoms of 1
respiratory limitation in approximately 15% of 
smokers. Changes in the small airways of young 
smokers will reverse after 1-2 years of cessation, there 
may be a small increase in measures of expiratory 
airflow following cessation among individuals who 
have developed chronic airflow obstruction, The major 
change following cessation is a slowing of the rate of 
decline in lung function with advancing age rather than 
1, 32a return of lung function toward/normal.
Although COPD can be the result of exposure to 
occupational hazards and air pollution across the 
world, cigarette smoking active or passive is the most 
commonly cited risk factor and is associated with a 
high prevalence of respiratory symptoms and lung 
function abnormalities, the two main types of COPD 
33are Chronic bronchitis and Emphysema.  Cigarette 
31,34smoking can cause cancer anywhere in the body.  
And is one of the most important causes of Cancer of 
the lungs, larynx, oral cavity, esophagus, pancreas, 
1,3,33 kidney and urinary bladder. There is also a growing 
evidence suggesting that cigarette may play a role in 
34,35increasing the risk of cervical and stomach cancer.  
However, there is conflicting evidence in the 
relationship of cigarette smoking and cancer of the 
breast, but overall there does appear to be slight causal 
link, more research is needed before a solid conclusion 
36can be made about a potential link.  There is increasing 
number of uterine cancer among post menopausal 
34women who smoke.  The risk of cancer increases with 
the increasing number of cigarette smoked per day and 
the duration of smoking (usually quantified as pack 
1,32years).  There appears to be a synergistic interaction 
between cigarette smoking and alcohol use for cancer 
of the oral cavity, esophagus and possibly lung 
37cancers.   Several occupational exposures also 
synergistically increase lung cancer risk among 
cigarette smokers, most notably occupational asbestos 
31and radon exposure . Cessation of smoking reduces 
the risk of developing cancer relative to continuing 
smoking, but even after 20 years of cessation, there is a 
modest persistent increase of developing lung 
1, 31, 32cancers.
PREGNANCY: Cigarette smoking is associated with 
several complication of pregnancy: premature rupture 
of membranes, abruptio placentae and placenta previa; 
there is also a small increase in the risk of spontaneous 
abortions among smokers. Infants of smoking mothers 
are more likely to experience preterm delivery, have a 
higher prenatal mortality, and most times are small for 
their gestational age, they are more likely to die of 
sudden infant death syndrome, bronchiolities and 
appear to have a development lag for at least the first 
 1, 38several years of life.  
as well as small vessel disease. Approximately 90% of 
peripheral vascular disease in non diabetic population 
1,28 can be attributed to cigarette smoking. And 
approximately 10% of exclusive cerebrovascular 
1disease are caused by cigarette smoking.  Cigarette 
smoking acutely exert an hypertensive effect, mainly 
through stimulation of sympathetic nervous system, 
hypertensive smokers are more likely to develop 
severe form of hypertension, including malignant and 
29renovascular hypertension .  There is a multiplier 
effect between cigarette smoking and other cardiac risk 
factors, such that the increment in risk produced by 
smoking among individuals with hypertension or 
elevated serum lipids is greater than the increase in risk 
produced by smoking for individuals without this risk 
1,29 factors.
Cigarette smoking also increases the likelihood of 
myocardial infarction (MI) and sudden cardiac death 
by promoting platelet aggregation and vascular 
occlusion, the cessation of smoking has been shown to 
be accompanied by a reduction in a new coronary event 
1in those that have survived the first MI.   This could also 
explain the high rates of graft occlusion among those 
who continue to smoke following vascular by pass 
surgery for cardiac or peripheral vascular disease, as 
well as the high rate of failure of angioplasty procedure 
1, 2, 4among continuing smokers.  Cessation of cigarette 
smoking reduces the risk of second coronary event 
within 6-12 month after quitting, and rates of first 
myocardial infarction or death from coronary heart 
disease  within the first few years after 15 years of 
1, 2cessation . The risk of a new myocardial infarction or 
death from coronary heart disease in those who have 
smoked in the past is similar to that in those who have 
1, 2, 4never smoked.  The importance of smoking has been 
confirmed as the cause of acute myocardial infarction, 
about 50% of non fatal infarct can be attributable to 
30cigarette smoking.
RESPIRATORY DISEASES: Respiratory diseases 
such as COPD, Lung cancer, Pneumonia, Tuberculosis 
and Asthma has well been associated with cigarette 
31smoking.  Cigarette smoking is responsible for >90% 
of chronic obstructive pulmonary disease (COPD) 
within 1-2years of beginning to smoke regularly, many 
young smokers will develop inflammatory changes 
which do not predict development of chronic air flow 
1,31,32obstruction.   After over >20years of smoking 
pathophysiologic changes in the lungs develops and 
progresses proportionately to smoking intensity and 
duration. Chronic mucosal hyperplasia of the larger 
airways results in a chronic productive cough in as 
1, 31many as 50% of smokers over 66years.  Chronic 
inflammation and narrowing of the small airways and 
/or enzymatic digestion of alveolar walls resulting in 
pulmonary emphysema can result in reduced 
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contemplation- not thinking about quitting. 
Contemplation stage-thinking about quitting but not 
ready to quit. Preparation stage-getting ready to quit. 
Action-quitting and Maintenance-remaining a non-
1,41smoker.  A successful conceptualization of the 
cessation process is one where smokers cycle through 
the stages of cessation, each time smokers go round the 
cycle, a few more smokers become successful in their 
1,41,42cessation effort.  One goal of clinician based 
smoking intervention lies between moving smokers 
from one stage of the cessation cycle to another, and 
effort can be focused in moving the smokers to the next 
6stage rather than focusing exclusively on cessation.  
The move from thinking about quitting to making a 
quit attempt is often triggered by a variety of 
environmental stimuli independent of physician 
control. The cost of cigarette can be a powerful trigger 
1for cessation attempts.  Media campaigns, particularly 
when coupled with cessation events are also able to 
trigger cessation attempts in a large numbers of 
smokers. Changes in workplace rules, such as 
restricting smoking in the workplace have been 
associated with quit attempts in a substantial number 
of workers. Physician's can use the five A's frame work 
1,43(ask, advise, assess, assist and arrange).  Physician's 
advice to quit particularly around an acute illness is 
also a powerful trigger for cessation attempts, with 
about half of patients who are advised to quit, making a 
1cessation attempt.  Telephone counseling and nicotine 
replacement therapy are all useful enhancer of long 
term cessation. Successful clinic based cessation for 
those who can be recruited to participate, and a 
physician's recommendation can double the fraction of 
smokers who are willing to participate in these 
1programme.  Other modalities are: Cut down to quit- 
gradual reduction which slowly reduces ones daily 
intake of nicotine. Community intervention-multiple 
channels to provide reinforcement, support, and norms 
for not smoking has an effect on smoking cessation 
44outcomes among adults.  Psychosocial approaches-
group or individual psychological support can help 
people who want to quit, this form of counselling can 
be effective alone or in combination with medication. 
These counselling styles include, motivational 
interviewing, cognitive behavioral therapy, acceptance 
45, 46and commitment therapy.  Self Help- Cochrane 
review found that self-help material such news group, 
nicotine anonymous, mobile phone, self-help books, 
spirituality, interactive web based and stand-alone 
computer programme may produce only a small 
47increase in quit rates.  Biochemical feedback-This 
include various method which allow smokers to see the 
impact of their tobacco use, carbon dioxide (CO) 
concentration in the blood has direct correlation with 
CO in the blood known as percent carboxyhemoglobin, 
the demonstration of CO concentration to a smoker 
through noninvasive breath sample, this links the 
OTHER CONSIDERATIONS: Smoking delays 
healing of peptic ulcers; increase the risk of 
osteoporosis ,  seni le  cataract  and macular  
degeneration, it also results in premature menopause, 
wrinkling of the skin, gallstones and cholecystitis in 
1, 39women and impotence in males.  
ENVIROMENTAL TOBACCO SMOKE: Prolonged 
exposure to a second hand tobacco smoke, increase the 
risk of lung cancer and coronary artery disease among 
non smokers. It also increases the incidence of 
respiratory infections, chronic otitis media, and can 
lead to asthma exacerbation and a probable cause in 
1, 7children.
PHARMACOLOGICAL INTERRACTIONS:
Cigarette smoking may interact with a variety of other 
drugs in a way that may have clinically significant 
implications it can affect drug therapy by both 
pharmacokinetic and pharmacodynamics mechanism, 
enzyme induced by tobacco smoking may also increase 
the risk of cancer by enhancing the metabolic activation 
1,43of carcinogens.  Polycyclic aromatic hydrocarbon 
cigarette induce the cytochrome  P450 (CYP) system 
which may affect the metabolic clearance of variety of 
drugs such as theophylline, propranalol, haloperidol, 
imipramine, pentazocin, flecanide , estradiol, heparine, 
40caffeine, tocrine.  This effect may result in more drug 
toxicity among non smokers on a fixed drug dosage 
schedules and inadequate serum levels in smokers as 
outpatients, when the dosage is established in the 
hospital under non smoking conditions. Although the 
inhibitory effect of the smoke constituents carbon 
monoxide and cadmium on CYP enzyme has been 
observed in invitro and animal model studies, the 
relevance of this inhibition in humans has not yet been 
established. The mechanism involved in most 
interactions between cigarette smoking and drugs 
4 3i n v o l v e s  t h e  i n d u c t i o n  o f  m e t a b o l i s m .  
Correspondingly serum levels may rise when smokers 
may also have higher first pass clearance for drugs such 
as lidocane, and the stimulant effects of nicotine may 
1, 40reduce the effect of benzodiazepines or beta blockers.
CESSATION OF SMOKING: The process of stopping 
smoking is often a cyclical one, with the smoker making 
multiple attempts to quit and failing before finally 
being successful, tobacco contains nicotine which is 
additive. Approximately 70 to 80% of smokers would 
like to quit smoking, about 13% of current smokers 
attempt to quit smoking each year and >90% of those 
1,41unassisted quit attempts fail.  Smokers have been 
categorized into those who are not thinking about 
quitting (contemplation) and those who are in the 
1action phase of quitting. Smokers generally go through 
five successive stages in the process of quitting, each 
involving different issues and challenges, these are pre-
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effective strategy for reducing tobacco use. The 
effectiveness of tobacco tax increases is enhanced when 
implemented as part of a comprehensive tobacco 
53,56control strategy . Increasing tobacco taxation has 
been classified as a “phenomenal” intervention within 
the framework of the Sustainable Development Goals. 
WHO estimates the cost of implementing and 
administering tobacco tax increases at US$ 0.05 per 
person per year in low- and middle-income countries, 
54, making it the least costly of all tobacco control policies
55, 56. Not only is tobacco taxation cost-effective and 
efficient to implement, it also has the potential to 
generate significant additional revenue for 
governments to fund health programmes and other 
essential services. Evidence from a growing number of 
countries shows that tax increases that lead to a 10% 
rise in retail tobacco product prices will cut 
consumption by 2% to 8%. In low-income countries, for 
example, a doubling of excise tax per packet of 
cigarettes increases cigarette tax revenues by more than 
5630% .”
The Framework Convention on Tobacco Control by 
The World Health Organization, (WHO) have made 
specific commitments to implement strong tobacco 
control policies as an important means of providing 
that protection. WHO introduced the “MPOWER” 
56package  of measures to assist in the country-level 
implementation of effective interventions to reduce the 
demand for tobacco.  The six components of MPOWER 
are: monitor tobacco use and prevention policies; 
protect people from tobacco smoke; offer help to quit 
tobacco use; warn about the dangers of tobacco; enforce 
bans on tobacco advertising, promotion and 
56sponsorship and raise taxes on tobacco .
Today, more than half of the world's countries, with 
nearly 40% of the world's population (2.8 billion 
people), have implemented at least one MPOWER 
measure to the highest level of achievement and many 
countries have implemented multiple MPOWER 
56measures to the highest level . 
The Nigerian government has spent N5, 500,000 on 
55tobacco control based on recent report . The Nigerian 
government has implemented some aspect of the 
MPOWER. Below is the summary of the level of 
implementation of the MPOWER
1. Monitor tobacco use and prevention policies: 
There exist recent and representative data 
from either adults or youth 
2. Protect people from tobacco smoke: Three to 
Five public places completely smoke free 
3. Offer help to quit tobacco use: There exist some 
cessation services (at least one of which is cost-
covered)
4. Warn about the dangers of tobacco: No 
warning services or small warning 
smoking habit and physiological harm associated with 
47smoking, this might aid in quitting.  Cotinine a 
metabolite of nicotine is present in smokers like CO, a 
cotinine test can serve as a reliable biomarker to 
determine smoking status, this could be tested through 
urine, blood, saliva or hair samples, with its only 
48concern being it invasiveness. These two methods can 
be used either alone or in combination, for instance in 
situation where abstinence verification needs 
49additional verifications.  Other methods used include 
completion and incentives through quit and win promos, 
Health care system based intervention through advice by 
healthcare providers, substitute for cigarrete like e-cigarrete 
have all been found to have some degree of success in 
50quitting smoking.  
PHYSICIANS INTERVENTION: There is a 
health care policy and research clinical guidelines for 
51smoking cessation.  All patients should be asked 
whether they smoke, their past experience with 
quitting and whether they are currently interested in 
1,54quitting.  Those who are not interested in quitting 
should be encouraged and motivated to quit, they 
should be provided with a clear, strong and 
personalized physician message that smoking is an 
important health concern, and offered the assistance. A 
quit date should be negotiated, usually not the visiting 
days but within few weeks and a follow up contact by 
office staff around the times of the quit date should be 
1,51provided.  The American cancer society estimate that 
between 25 and 33% of smokers who use medicine can 
42stay smoke-free for over 6 months.  There are a variety 
of nicotine replacement products including over the 
counter nicotine patch and gum, as well as nicotine 
1,44nasal and oral inhalers available by prescription.    
Drugs like clonidine and recently Bupropion which is 
an anti depressant drug have also been shown to be 
1,44,42effective in smoking cessation.  Some evidence 
supports the combination of nicotine replacement 
therapy and anti depressants. Nicotine replacement 
therapy is provided in different dosage for use with 
smokers of different number of cigarette smoked per 
42day.  Anti-depressant is more effective in those with a 
history of  depressive symptoms.  A more 
comprehensive approach with pharmacological 
assistance and counseling can increase cessation 
1, 42success of smokers by three folds.  the following 
changes are essential in institutionalizing smoking 
1intervention with medical practice. 
1. Asking of smoking habit and interest in 
cessation
2. Listing smoking as part of the problem in 
the medical record.
3. Automating follow up with patient on 
their quit date.
CONTROL OF TOBACCO SMOKING
Raising tobacco taxes is the most effective and cost-
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taxes will both generate extra revenue to fund health 
programmes and other essential services and also 
reduce consumption. 
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